Chapter

Pharmacological management: disease-modifying drugs

Edited by Susan M. Oliver

in Oxford Handbook of Musculoskeletal Nursing

Published on behalf of Oxford University Press

ISBN: 9780199238330
Published online August 2010 | e-ISBN: 9780199597994 | DOI: http://dx.doi.org/10.1093/med/9780199238330.003.0016

Series: Oxford Medical Handbooks

Pharmacological management: disease-modifying drugs

More Like This

Show all results sharing these subjects:

  • Rheumatology
  • Pharmacology

GO

Show Summary Details

Preview

Pharmacological management: pre-treatment assessment - Screening before treatment: documentation and decisions - Disease-modifying anti-rheumatic drugs - Traditional disease-modifying anti-rheumatic drugs - Azathioprine and ciclosporin - D-penicillamine and sodium aurothiomalate (intramuscular gold) - Hydroxychloroquine sulfate - Leflunomide - Methotrexate - Mycophenolate mofetil - Sulfasalazine - Tacrolimus - Corticosteroids: overview - Corticosteroids: preparations and routes of administration - New disease-modifying drugs: biologic therapies - Treatment with biologic therapies: key points - Anti-tumour necrosis factor alpha: overview - B-cell (CD-20) depletion therapies - New biologic disease-modifying therapies - New biologic disease-modifying therapies: abatacept and certolizumab pegol - Follow-up care for those on biologic disease-modifying anti-rheumatic drugs - Frequently asked questions

Chapter.  12485 words.  Illustrated.

Subjects: Rheumatology ; Pharmacology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.